Share on LinkedInShare on LinkedIn

ARTICLE · 19 OCTOBER 2018

What Are The Top Hatch-Waxman And BPCIA Developments For September 2018?

Morrison Foerster
Morrison Foerster
Contributor
Morrison Foerster

Morrison Foerster

With approximately 1,000 lawyers in 19 offices, Morrison & Foerster is a preeminent global law firm...

View firm profile
Explore more from Morrison Foerster

This month we highlight the possibility that the Supreme Court will consider the standard for adequacy of written description and a Federal Circuit exposition on the relationship between "blocking patents" and objective indicia of nonobviousness.

United StatesIntellectual Property

This month we highlight the possibility that the Supreme Court will consider the standard for adequacy of written description and a Federal Circuit exposition on the relationship between "blocking patents" and objective indicia of nonobviousness.

CASES

Supreme Court

Written Description at the Supreme Court?

Amgen, Inc. v. Sanofi (cert. petition)

On September 18, the Supreme Court requested a brief responding to Amgen's cert. petition. The question presented by Amgen is: "Whether the standard for determining the adequacy of the "written description of the invention" should be as the statute says—that the description must be "in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains . . . to make and use the same" — or whether court-created standards should control instead."

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

See more popular content from